← Open Payments lookup

CLYDE YAN: Open Payments

NPI 1922558865 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,001 in 126 payments from 19 companies in 2025. Trend: 2023 $2,135 · 2024 $2,098 · 2025 $2,001

Food & beverage: $1,994Education: $8
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.27$317
Neurocrine BioSciences, Inc.16$235
Otsuka America Pharmaceutical, Inc.15$227
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$181
Janssen Pharmaceuticals, Inc11$179
Vanda Pharmaceuticals Inc.6$167
Axsome Therapeutics, Inc.10$141
Collegium Pharmaceutical, Inc.4$78
Takeda Pharmaceuticals U.S.A., Inc.4$78
Corium, LLC5$64

Products named: Qelbree, INGREZZA, REXULTI, CAPLYTA, SPRAVATO, HETLIOZ, Auvelity, Jornay PM.

Industry payments across IN — which companies pay providers there.